iBio
iBio is developing plant-based Virus Like Particles (VLP) for the treatment of SARS-CoV-2 using its FastPharming System (in collaboration with Texas A&M University System)
Rankings by 
National Ranking
343rd
in United StatesRegional Ranking
387th
in North America and CaribbeanGlobal Ranking
928th
worldwide